Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide Stress Test to Predict RRT in Ischemic ATN
NCT03731117Phase 4Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2019
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 4, open-label trial of furosemide in acute kidney injury (AKI), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Need for renal replacement therapy or death at 7 days and Sensitivity at 3 hours. Started Jul 2019; status: terminated.
02
Drugs
furosemide
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT03731117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03731117.